Fritz Boege

4.5k total citations
98 papers, 3.5k citations indexed

About

Fritz Boege is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Fritz Boege has authored 98 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 17 papers in Oncology and 13 papers in Toxicology. Recurrent topics in Fritz Boege's work include Cancer therapeutics and mechanisms (42 papers), Receptor Mechanisms and Signaling (17 papers) and DNA Repair Mechanisms (14 papers). Fritz Boege is often cited by papers focused on Cancer therapeutics and mechanisms (42 papers), Receptor Mechanisms and Signaling (17 papers) and DNA Repair Mechanisms (14 papers). Fritz Boege collaborates with scholars based in Germany, Denmark and United States. Fritz Boege's co-authors include Morten O. Christensen, Christian Mielke, Tobias Straub, Birgitta R. Knudsen, Hans Barthelmes, Martin J. Lohse, Roland Jahns, Valérie Boivin, Doris Marko and Anni H. Andersen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Fritz Boege

96 papers receiving 3.4k citations

Peers

Fritz Boege

ONCOL

CCM

Michel Gallant Canada

Janice M. Zabolotny United States

Takashi Izumi Japan

Seok‐Yong Lee United States

Fraydoon Rastinejad United States

Zhimin Wang China

Boris V. Chernyak Russia

Riccardo Ghidoni Italy

Margarita García‐Calvo United States

Paolo Grieco Italy

Michel Gallant Canada

Fritz Boege

3.5k ×1.5

782 ×1.4

ONCOL

171 ×0.4

CCM

399 ×1.2

174 ×0.6

Citations per year, relative to Fritz Boege Fritz Boege (= 1×) peers Michel Gallant

Countries citing papers authored by Fritz Boege

Since Specialization

Citations

This map shows the geographic impact of Fritz Boege's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fritz Boege with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fritz Boege more than expected).

Fields of papers citing papers by Fritz Boege

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fritz Boege. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fritz Boege. The network helps show where Fritz Boege may publish in the future.

Co-authorship network of co-authors of Fritz Boege

This figure shows the co-authorship network connecting the top 25 collaborators of Fritz Boege. A scholar is included among the top collaborators of Fritz Boege based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fritz Boege. Fritz Boege is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoffmann, Till, et al.. (2025). Evaluation of alcohol intoxication on primary and secondary haemostasis – results from comprehensive coagulation testing. International Journal of Legal Medicine. 139(4). 1797–1808. 1 indexed citations

Boege, Fritz, et al.. (2024). The Post-Acute COVID-19-Vaccination Syndrome in the Light of Pharmacovigilance. Vaccines. 12(12). 1378–1378. 6 indexed citations

Heidecke, Harald, M. Schott, Falk Steffen, et al.. (2024). Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS). Vaccines. 12(7). 790–790. 7 indexed citations

Zweck, Elric, Daniel Scheiber, Harald Heidecke, et al.. (2023). Receptor Autoantibodies: Associations with Cardiac Markers, Histology, and Function in Human Non-Ischaemic Heart Failure. ESC Heart Failure. 10(2). 1258–1269. 6 indexed citations

Weinhold, Sandra, Fritz Boege, Ortwin Adams, et al.. (2022). A Diagnostic Strategy for Gauging Individual Humoral Ex Vivo Immune Responsiveness Following COVID-19 Vaccination. Vaccines. 10(7). 1044–1044. 2 indexed citations

Backhaus, Insa, Derik Hermsen, Jörg Timm, et al.. (2022). SARS-CoV-2 seroprevalence and determinants of infection in young adults: a population-based seroepidemiological study. Public Health. 207. 54–61. 3 indexed citations

Nikolaev, Viacheslav O., et al.. (2020). Unmasking Features of the Auto-Epitope Essential for β1-Adrenoceptor Activation by Autoantibodies in Chronic Heart Failure. ESC Heart Failure. 7(4). 1830–1841. 9 indexed citations

Fuellen, Georg, Paul N. Schofield, Thomas Flatt, et al.. (2015). Living Long and Well: Prospects for a Personalized Approach to the Medicine of Ageing. Gerontology. 62(4). 409–416. 7 indexed citations

Kalfalah, Faiza, Kai Safferling, Petra Boukamp, et al.. (2015). Characterization of Skin Aging–Associated Secreted Proteins (SAASP) Produced by Dermal Fibroblasts Isolated from Intrinsically Aged Human Skin. Journal of Investigative Dermatology. 135(8). 1954–1968. 157 indexed citations

10.

Kalfalah, Faiza, Julia Tigges, Ellen Fritsche, et al.. (2014). Inadequate mito-biogenesis in primary dermal fibroblasts from old humans is associated with impairment of PGC1A-independent stimulation. Experimental Gerontology. 56. 59–68. 34 indexed citations

11.

Boege, Fritz, et al.. (2012). Drug‐like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart function. British Journal of Pharmacology. 166(3). 847–857. 24 indexed citations

12.

Weidtkamp‐Peters, Stefanie, Stephanie Schmitmeier, Claus A. M. Seidel, et al.. (2012). Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization. Cardiovascular Research. 97(3). 472–480. 39 indexed citations

13.

Christensen, Morten O., et al.. (2004). Distinct Effects of Topoisomerase I and RNA Polymerase I Inhibitors Suggest a Dual Mechanism of Nucleolar/Nucleoplasmic Partitioning of Topoisomerase I. Journal of Biological Chemistry. 279(21). 21873–21882. 37 indexed citations

14.

Boege, Fritz, Harald Biersack, & Peter Meyer. (1994). Drug-Sensitivity and DNA-Binding of a Subform of Topoisomerase Iiα in Resistant Human HL-60 Cells. Acta Oncologica. 33(7). 799–806. 4 indexed citations

15.

Boege, Fritz. (1993). Measuring Bence Jones proteins with antibodies against bound immunoglobulin light-chains: how reliable are the results?. PubMed. 31(6). 403–5. 3 indexed citations

16.

Boege, Fritz, et al.. (1993). Different Functional States of Topoisomerase II can be Discriminated by Orthovanadate Sensitivity in Multi-drug Resistant Human Leukemic Cells. Leukemia & lymphoma. 9(4-5). 381–383. 2 indexed citations

17.

Boege, Fritz, Eigil Kjeldsen, Frank Gieseler, Jan Alsner, & Harald Biersack. (1993). A drug‐resistant variant of topoisomerase IIα in human HL‐60 cells exhibits alterations in catalytic pH optimum, DNA binding and sub‐nuclear distribution. European Journal of Biochemistry. 218(2). 575–584. 11 indexed citations

18.

Boege, Fritz & Wolfgang Fischbach. (1991). Structural heterogeneity of faecal alpha 1 antitrypsin shown by immunoblot analysis in patients with Crohn's disease.. Gut. 32(5). 496–499. 5 indexed citations

19.

Cremaschi, Graciela, et al.. (1991). β-Adrenoceptor distribution in murine lymphoid cell lines. Immunopharmacology. 22(3). 195–206. 40 indexed citations

20.

Gieseler, Frank, Fritz Boege, & Melody S. Clark. (1990). Alteration of topoisomerase II action is a possible molecular mechanism of HL-60 cell differentiation.. Environmental Health Perspectives. 88. 183–185. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact